Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Clinical and genetic characteristics of sporadic adult-onset degenerative ataxia.

Giordano I, Harmuth F, Jacobi H, Paap B, Vielhaber S, Machts J, Schöls L, Synofzik M, Sturm M, Tallaksen C, Wedding IM, Boesch S, Eigentler A, van de Warrenburg B, van Gaalen J, Kamm C, Dudesek A, Kang JS, Timmann D, Silvestri G, Masciullo M, Klopstock T, Neuhofer C, Ganos C, Filla A, Bauer P, Tezenas du Montcel S, Klockgether T.

Neurology. 2017 Sep 5;89(10):1043-1049. doi: 10.1212/WNL.0000000000004311. Epub 2017 Aug 9.

PMID:
28794257
2.

Standardized Assessment of Hereditary Ataxia Patients in Clinical Studies.

Paap BK, Roeske S, Durr A, Schöls L, Ashizawa T, Boesch S, Bunn LM, Delatycki MB, Giunti P, Lehéricy S, Mariotti C, Melegh J, Pandolfo M, Tallaksen CME, Timmann D, Tsuji S, Schulz JB, van de Warrenburg BP, Klockgether T.

Mov Disord Clin Pract. 2016 Feb 11;3(3):230-240. doi: 10.1002/mdc3.12315. eCollection 2016 May-Jun. Review.

3.

Glatiramer acetate treatment effects on gene expression in monocytes of multiple sclerosis patients.

Thamilarasan M, Hecker M, Goertsches RH, Paap BK, Schröder I, Koczan D, Thiesen HJ, Zettl UK.

J Neuroinflammation. 2013 Oct 17;10:126. doi: 10.1186/1742-2094-10-126.

4.

Multiple sclerosis: modulation of toll-like receptor (TLR) expression by interferon-β includes upregulation of TLR7 in plasmacytoid dendritic cells.

Derkow K, Bauer JM, Hecker M, Paap BK, Thamilarasan M, Koczan D, Schott E, Deuschle K, Bellmann-Strobl J, Paul F, Zettl UK, Ruprecht K, Lehnardt S.

PLoS One. 2013 Aug 12;8(8):e70626. doi: 10.1371/journal.pone.0070626. eCollection 2013.

5.

Interferon-beta therapy in multiple sclerosis: the short-term and long-term effects on the patients' individual gene expression in peripheral blood.

Hecker M, Hartmann C, Kandulski O, Paap BK, Koczan D, Thiesen HJ, Zettl UK.

Mol Neurobiol. 2013 Dec;48(3):737-56. doi: 10.1007/s12035-013-8463-1. Epub 2013 May 1.

PMID:
23636981
6.

Elevated type I interferon-like activity in a subset of multiple sclerosis patients: molecular basis and clinical relevance.

Hundeshagen A, Hecker M, Paap BK, Angerstein C, Kandulski O, Fatum C, Hartmann C, Koczan D, Thiesen HJ, Zettl UK.

J Neuroinflammation. 2012 Jun 22;9:140. doi: 10.1186/1742-2094-9-140.

7.

An inventory of short term and long term changes in gene expression under interferon β treatment of relapsing remitting MS patients.

Paap BK, Hundeshagen A, Hecker M, Zettl UK.

Curr Pharm Des. 2012;18(29):4475-84. Review.

PMID:
22612748
8.

Integration of MicroRNA databases to study MicroRNAs associated with multiple sclerosis.

Angerstein C, Hecker M, Paap BK, Koczan D, Thamilarasan M, Thiesen HJ, Zettl UK.

Mol Neurobiol. 2012 Jun;45(3):520-35. doi: 10.1007/s12035-012-8270-0. Epub 2012 May 2.

PMID:
22549745
9.

Reassessment of blood gene expression markers for the prognosis of relapsing-remitting multiple sclerosis.

Hecker M, Paap BK, Goertsches RH, Kandulski O, Fatum C, Koczan D, Hartung HP, Thiesen HJ, Zettl UK.

PLoS One. 2011;6(12):e29648. doi: 10.1371/journal.pone.0029648. Epub 2011 Dec 27.

10.

MicroRNAs in multiple sclerosis and experimental autoimmune encephalomyelitis.

Thamilarasan M, Koczan D, Hecker M, Paap B, Zettl UK.

Autoimmun Rev. 2012 Jan;11(3):174-9. doi: 10.1016/j.autrev.2011.05.009. Epub 2011 May 18. Review.

PMID:
21621006
11.

Biodosimetry on small blood volume using gene expression assay.

Brengues M, Paap B, Bittner M, Amundson S, Seligmann B, Korn R, Lenigk R, Zenhausern F.

Health Phys. 2010 Feb;98(2):179-85. doi: 10.1097/01.HP.0000346706.44253.5c.

12.

Endogenous DNA damage clusters in human hematopoietic stem and progenitor cells.

Bennett P, Ishchenko AA, Laval J, Paap B, Sutherland BM.

Free Radic Biol Med. 2008 Nov 1;45(9):1352-9. doi: 10.1016/j.freeradbiomed.2008.08.007. Epub 2008 Aug 14.

PMID:
18775489
13.

Human abasic endonuclease action on multilesion abasic clusters: implications for radiation-induced biological damage.

Paap B, Wilson DM 3rd, Sutherland BM.

Nucleic Acids Res. 2008 May;36(8):2717-27. doi: 10.1093/nar/gkn118. Epub 2008 Mar 19.

14.

High-throughput fluorescent tagging of full-length Arabidopsis gene products in planta.

Tian GW, Mohanty A, Chary SN, Li S, Paap B, Drakakaki G, Kopec CD, Li J, Ehrhardt D, Jackson D, Rhee SY, Raikhel NV, Citovsky V.

Plant Physiol. 2004 May;135(1):25-38.

15.

CP12 provides a new mode of light regulation of Calvin cycle activity in higher plants.

Wedel N, Soll J, Paap BK.

Proc Natl Acad Sci U S A. 1997 Sep 16;94(19):10479-84.

16.

CP12: a small nuclear-encoded chloroplast protein provides novel insights into higher-plant GAPDH evolution.

Pohlmeyer K, Paap BK, Soll J, Wedel N.

Plant Mol Biol. 1996 Dec;32(5):969-78.

PMID:
8980547

Supplemental Content

Support Center